DrugPatentWatch Database Preview
Captopril - Generic Drug Details
» See Plans and Pricing
What are the generic drug sources for captopril and what is the scope of freedom to operate?
Captopril
is the generic ingredient in seven branded drugs marketed by Par Pharm, Ajanta Pharma Ltd, Annora Pharma, Apothecon, Boscogen, Cosette, Dava Pharms Inc, Egis Pharms, G And W Labs Inc, Hikma Intl Pharms, Mylan, Oxford Pharms, Prinston Inc, Purepac Pharm, Sandoz, Seton Pharms, Teva, Watson Labs, Wockhardt Ltd, Yaopharma Co Ltd, Ivax Sub Teva Pharms, and Vintage Pharms Llc, and is included in thirty-two NDAs. Additional information is available in the individual branded drug profile pages.There are fifteen drug master file entries for captopril. Thirteen suppliers are listed for this compound.
Summary for captopril
US Patents: | 0 |
Tradenames: | 7 |
Applicants: | 22 |
NDAs: | 32 |
Drug Master File Entries: | 15 |
Suppliers / Packagers: | 13 |
Bulk Api Vendors: | 106 |
Clinical Trials: | 41 |
Patent Applications: | 6,978 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price trends for captopril |
What excipients (inactive ingredients) are in captopril? | captopril excipients list |
DailyMed Link: | captopril at DailyMed |
Recent Clinical Trials for captopril
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Case Comprehensive Cancer Center | Phase 1/Phase 2 |
Kafrelsheikh University | Phase 2 |
Assistance Publique - Hôpitaux de Paris | Phase 2 |
Pharmacology for captopril
Drug Class | Angiotensin Converting Enzyme Inhibitor |
Mechanism of Action | Angiotensin-converting Enzyme Inhibitors |
Medical Subject Heading (MeSH) Categories for captopril
US Patents and Regulatory Information for captopril
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Vintage Pharms Llc | CAPTOPRIL AND HYDROCHLOROTHIAZIDE | captopril; hydrochlorothiazide | TABLET;ORAL | 074788-003 | Dec 29, 1997 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
Teva | CAPTOPRIL | captopril | TABLET;ORAL | 074322-003 | Feb 13, 1996 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
Vintage Pharms Llc | CAPTOPRIL AND HYDROCHLOROTHIAZIDE | captopril; hydrochlorothiazide | TABLET;ORAL | 074788-001 | Dec 29, 1997 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
Seton Pharms | CAPTOPRIL | captopril | TABLET;ORAL | 212223-001 | Oct 30, 2019 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for captopril
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Par Pharm | CAPOTEN | captopril | TABLET;ORAL | 018343-004 | Jun 13, 1995 | Start Trial | Start Trial |
Par Pharm | CAPOTEN | captopril | TABLET;ORAL | 018343-007 | Jun 13, 1995 | Start Trial | Start Trial |
Par Pharm | CAPOTEN | captopril | TABLET;ORAL | 018343-005 | Jan 17, 1985 | Start Trial | Start Trial |
Par Pharm | CAPOTEN | captopril | TABLET;ORAL | 018343-002 | Approved Prior to Jan 1, 1982 | Start Trial | Start Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:






Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.